• Corporate Message
  • Products
  • Corporate Information
  • Milestones
  • Careers

We contribute to society by applying our cutting edge technology and years of R&D experience in developing clinically effective and safe pharmaceutical products.

APIs & Pharmaceuticals
Life Science
  • AstaReal
  • Neusilin
  • Fujicalin
  • F-MELT

Contact Us

What's New

2024.01.05 New!
In regards to Ishikawa Noto Earthquake (final report)
2024.01.02 New!
In regards to Ishikawa-Noto Earthquake(second report)
2024.01.01 New!
In regards to Ishikawa-Noto Earthquake (preliminary report)
2021.02.22
Relocation of Tokyo Branch Office
2020.09.24
Fuji Excipient Webinar September 24
2020.06.23
Fuji Excipient Webinar June 23-24
2020.06.17
Fuji increases its production capacity for the API manufacturing of Avigan® Tablet.
2019.09.25
Hiroshi Nishida assumes his new role as a CEO & President starting October 1, 2019
2019.04.01
Business Transfer of ULCERLMIN® for the Treatment of Gastritis/Peptic Ulcer from Chugai Pharmaceutical to Fuji Chemical Industries
2017.06.26
Oldamin Injection 1g is approved for an additional indication (sclerosing regression of gastric varices) in Japan

Event

2020.06.15
June 23-24 Fuji Excipient Webinar (Asia Pacific and Europe)
2019.10.11
AAPS 2019 – Nov. 5–7
2019.10.10
CPhI Worldwide 2019 - Nov. 5-7
2019.08.04
Contract Pharma 2019 - Sept. 26-27
2019.05.27
Interphex Japan 2019 - July 3-5
2019.03.27
CPhI North America 2019 - April 30 - May 2
2018.06.11
AAPS 2018 – Nov. 4–7

Technical Newsletter

Affiliate Company

Fuji Health Science, Inc
Marketing and sales of bulk pharmaceutical products in the U.S.A
AstaReal Be you, Just healthier
AstaReal Co.,Ltd.
Japan
AstaReal AB
Sweden
AstaReal,Inc.
USA
AstaReal Pty Ltd
Singapore
AstaReal(India) Private Limited
India
Nishida Museum
Our philanthropic activity acquired a collection of worldwide fine arts and antiquities.